A receptor for infectious and cellular prion protein

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 7, 1999, Pages 853-859

  Martins, V R ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Encephalopathies; Prion; PrPc Receptor; Transmissible spongiform

Indexed keywords

ANIMALIA;

CELL SURFACE RECEPTOR; PRION PROTEIN; PRPC RECEPTOR;

ANIMAL; HAMSTER; HUMAN; METABOLISM; MOUSE; PRION DISEASE; REVIEW;

ANIMALS; CRICETINAE; HUMANS; MICE; PRION DISEASES; PRPC PROTEINS; PRPSC PROTEINS; RECEPTORS, CELL SURFACE;

EID: 0033163257     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000700009     Document Type: Article

References (59)

1. Gordon WS (1946). Advances in veterinary research. Veterinary Record, 58: 518-525.
2. Prusiner SB (1991). Molecular biology of prion diseases. Science, 252: 1515-1522.
3. Prusiner SB (1993). Genetic and infectious prior diseases. Archives of Neurology, 50: 1129-1153.
4. Grifft JS (1967). Self replication and scrapie. Nature, 215: 1043-1044.
5. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science, 216: 136-144.
6. Bolton DC, McKinley MP & Prusiner SB (1982). Identification of a protein that purifies with the scrapie prion. Science, 218: 1309-1311.
7. Prusiner SB, Groth DF, Bolton DC, Kent SB & Hood LE (1984). Purification and structural studies of a major scrapie prion protein. Cell, 38: 127-134.
8. Oesch B, Westaway D, Walchl M, McKinley MP, Kent SB, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, Prusiner SB & Weissmann C (1985). A cellular gene encodes scrapie PrP 27-30 protein. Cell, 40: 735-746.
9. Chesebro B, Race R, Wehrly K, Nishio J, Bloom M, Lechner D, Bergstrom S, Robbins K, Mayer L, Keith JM, Garon C & Haase A (1985). Identification of scrapie prion protein-specific mRNA in scrapie infected and uninfected brain. Nature, 315: 331-333.
10. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE & Prusiner S (1993). Conversion of alpha-helices into beta-sheet features in the formation of the scrapie prion proteins. Proceedings of the National Academy of Sciences, USA, 90: 10962-10966.
11. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R & Wuthrich K (1996). NMR structure of the mouse prion protein domain PrP (121-231). Nature, 382: 180-182.
12. McKinley MP, Bolton DC & Prusiner SB (1983). A protease-resistant protein is a structural component of the scrapie prion. Cell, 35: 57-62.
13. Prusiner SB (1989). Scrapie prions. Annual Review of Microbiology, 43: 345-374.
14. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M & Weissmann C (1993). Mice devoid of PrP are resistant to scrapie. Cell, 73: 1339-1347.
15. Norwich AL & Weissmann JS (1997). Deadly conformations - Protein misfolding in prion disease. Cell, 89: 499-510.
16. Aguzzi A & Weissmann C (1997). Prions research: the next frontiers. Nature, 389: 795-798.
17. Scott M, Foster P, Mirenda C, Serban D, Coufal F, Walchli M, Tarchia M, Groth D, Carlson G, DeArmond SJ, Westaway D & Prusiner SB (1989). Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell, 59: 847-857.
18. Prusiner SB, Scott M, Foster D, Pan KM, Groth D, Mirenda C, Torchia M, Yang SL, Serban D, Carlson GA, Hoppe PC, Westaway D & DeArmond SJ (1990). Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell, 63: 673-686.
19. Telling GC, Scott M, Hsiao KK, Foster D, Yang SL, Torchia M, Sidle KC, Collinge J, DeArmond SJ & Prusiner SB (1994). Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proceedings of the National Academy of Sciences, USA, 91: 9936-9940.
20. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, DeArmond SJ & Prusiner SB (1995). Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell, 83: 79-90.
21. Bruce M, Chree A, McConnell I, Foster J, Pearson G & Fraser H (1994). Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philosophical Transactions of the Royal Society of London, Series B. Biological Sciences, B343: 405-411.
22. Collinge J, Sidle KCL, Meads J, Ironside J & Hill AF (1996). Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature, 383:685-690.
23. Hadlow WJ (1959). Scrapie and Kuru. Lancet, 2: 289-290.
24. Prusiner SB (1996). Molecular biology and pathogenesis of prion diseases. Trends in Biochemical Sciences, 21: 482-487.
25. Tateishi J, Brown P, Kitamoto T, Hoque ZM, Roos R, Wollman R, Cervenakova L & Gajdusek DC (1995). First experimental transmission of fatal familial insomnia. Nature, 376: 434-435.
26. Samaia HB, Mari JJ, Vallada HP, Moura RP, Simpson ATG & Brentani RR (1997). A prion-linked psychiatric disorder. Nature, 390: 241.
27. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J & Prusiner SB (1989). Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature, 338: 342-355.
28. Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, Avrahami D, Scarlato G, Abramsky O, Prusiner SB & Gabizon R (1991). Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. New England Journal of Medicine, 324: 1091-1097.
29. Gajdusek DC (1977). Unconventional viruses and the origin and disappearance of kuru. Science, 197: 943-960.
30. Bateman D, Hilton D, Love S, Zeidler M, Beck J & Collinge J (1995). Sporadic Creutzfeldt-Jakob disease in an 18-year-old in the UK. Lancet, 346: 1155-1156.
31. Cousens SN, Vynnycky E, Zeidler M, Will RG & Smith PG (1997). Predicting the CJD epidemic in humans. Nature, 385: 197-198.
32. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M & Weissmann C (1992). Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature, 356: 577-582.
33. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR & Jefferys JG (1994). Prion protein is necessary for normal synaptic function. Nature, 370: 295-297.
34. Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rulicke T, Moser M, Oesch B, McBride PA & Manson JC (1996). Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature, 380: 639-642.
35. Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu K, Sugimoto T, Nakatani A, Kataoka Y, Houtani T, Shirabe S, Okada H, Hasagawa S, Miyamoto T & Noda T (1996). Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature, 380: 528-531.
36. Cashman NR, Loertsche R, Nalbantoglu J, Shaw I, Kascsak RJ, Bolton DC & Bendheim PE (1990). Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell, 61: 185-192.
37. Whatley SA, Powell JF, Politopoulou G, Campbell IC, Brammer MJ & Percy NS (1995). Regulation of intracellular free calcium levels by the cellular prion protein. NeuroReport, 6: 2333-2337.
38. Miura T, Hori-i A & Takeuchi H (1996). Metal-dependent alpha-helix formation promoted by the glycine-rich octapeptide region of prion protein. FEBS Letters, 396: 248-252.
39. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer W, Giese A, Westaway D & Kretzschmar H (1997). The cellular prion protein binds copper in vivo. Nature, 390: 684-687.
40. Karlin KD & Tyeklar Z (1993). Bioinorganic Chemistry of Copper. Chapman and Hall, London.
41. Brown DR, Schulz-Schaeffer WJ, Schmidt B & Kretzschmar HA (1997). Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Experimental Neurology, 146: 104-112.
42. Stahl N, Borchelt DR, Hsiao K & Prusiner SB (1987). Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell, 51: 229-240.
43. Borchelt DR, Scott M, Taraboulos A, Stahl N & Prusiner SB (1990). Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. Journal of Cell Biology, 110: 743-752.
44. Shyng SL, Huber MT & Harris DA (1993). A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. Journal of Biological Chemistry, 268: 15922-15928.
45. Shyng S-L, Heuser JE & Harris DA (1994). A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. Journal of Cell Biology, 125: 1239-1250.
46. Vey M, Pilkuhn S, Wille H, Nixon R, DeArmond SJ, Smart EJ, Andersen RG, Taraboulos A & Prusiner SB (1996). Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proceedings of the National Academy of Sciences, USA, 93: 14945-14949.
47. Yehiely F, Bamborough P, Da Costa M, Perry BJ, Thinakaran G, Cohen FE, Carlson GA & Prusiner SB (1997). Identification of candidate proteins binding to prion protein. Neurobiology of Disease, 3: 339-355.
48. Martins VR, Graner E, Garcia-Abreu J, Souza SJ, Mercadante AF, Veiga SS, Zanata SM, Neto VM & Brentani RR (1997). Complementary hydropathy identifies a cellular prion protein receptor. Nature Medicine, 3 1376-1382.
49. Brentani RR (1988). Biological implications of complementary hydropathy of amino acids. Journal of Theoretical Biology, 135: 495-499.
50. Brentani RR (1990). Complementary hydropathy and the evolution of interacting polypeptides. Journal of Molecular Evolution, 31: 239-243.
51. Baranyi L, Campbell W, Ohshima K, Fujimoto S, Boros M & Okada H (1995). The antisense homology box: A new motif within proteins that encodes biological active peptides. Nature Medicine, 1: 894-901.
52. Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O & Tagliavini F (1993). Neurotoxicity of a prion protein fragment. Nature, 362: 543-546.
53. Shyng S-L, Moulder KJ, Laesko A & Harris DA (1995). The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits. Journal of Biological Chemistry, 270: 14793-14800.
54. Gasset M, Baldwin MA, Lloyd DH, Gabriel JM, Holtzman DM, Cohen F, Fletterick R & Prusiner SB (1992). Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. Proceedings of the National Academy of Sciences, USA, 89: 10940-10944.
55. Askanas V, Bilak M, Engel WK, Leclec A & Tome F (1993). Prion protein is strongly immunolocalized at the postsynaptic domain of the human neuromuscular junctions. Neuroscience Letters, 159: 111-114.
56. Hill AF, Zeidler M, Ironside J & Collinge J (1997). Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet, 349: 99-100.
57. Kimberlin RH & Walker CA (1989). Pathogenesis of scrapie in mice after intragastric infection. Virus Research, 12: 213-220.
58. Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, Bluethmann H, Bootz F, Suter M, Zinkernagel RM & Aguzzi A (1997). A crucial role for B cells in neuroinvasive scrapie. Nature, 390: 687-690.
59. Brandner S, Raeber A, Sailer A, Blattler T, Fischer M, Weissmann C & Aguzzi A (1996). A normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proceedings of the National Academy of Sciences, USA, 93: 13148-13151.